Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis

Abroad (travel likely)RecruitingPHASE2

Conditions

Interstitial Lung Disease · Pulmonary Fibrosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Sydney Montesi) · cfromson@mgh.harvard.edu · 617 643 3260
Contact: Principal Investigator (Sydney Montesi, MD)

Study leads

Sydney Montesi, MD
Principal Investigator
Massachusetts General Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Interstitial Lung Disease Research Unit Biobank

Interstitial Lung Disease · Sarcoidosis · Idiopathic Pulmonary Fibrosis

Abroad (travel likely)Recruiting

Kansas City, United States

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

Familial Pulmonary Fibrosis · Interstitial Lung Abnormalities · Interstitial Lung Diseases

Abroad (travel likely)RecruitingPHASE3

Los Angeles, United States · Aurora, United States

Radiologic Features of Rheumatoid Arthritis Interstitial Lung Disease at Chest High Resolution Computed Tomography

Reumatoid Arthritis · Interstitial Lung Disease Due to Systemic Disease (Disorder) · Idiopathic Pulmonary Fibrosis (IPF)

Abroad (travel likely)Recruiting

Prague, Czechia · Ferrara, Italy

FAPI PET for Lung Fibrosis

Interstitial Lung Disease · Idiopathic Interstitial Pneumonias · Drug-Induced Pneumonitis

Abroad (travel likely)RecruitingEARLY_PHASE1

Los Angeles, United States